mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.007 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.009 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |